Integrated DNA Technologies Celebrates Grand Opening of Flagship European Facility
News Sep 24, 2008
Integrated DNA Technologies (IDT) has celebrated the grand opening of its flagship European facility in Haasrode Research Park, Leuven, Belgium.
According to Company, the 2000 m2 research and production site enables IDT to serve customers throughout Europe, the Middle-East, and Africa with the same speed and quality that have made IDT the industry leader in the United States.
Dr. Joseph A. Walder, IDT’s founder and CEO, led the grand opening event. He emphasized that Europe is IDT’s most important market outside North America, and that IDT has invested in the heart of Europe as part of its long-range strategy to serve the research community globally.
“Although our origins are in the U.S., IDT is now just as much a European company as we are an American one,” Dr. Walder stressed.
“We want researchers in Europe to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis,” Dr. Walder continued, “and we want to learn from our European colleagues how IDT can best support their research as the science and application of synthetic biology advances.”
Joining IDT and its many guests was the Mayor of Leuven, Louis Tobback, who expressed his gratitude for IDT’s commitment to Europe and to Belgium. Thanking Dr. Walder in particular, he spoke on behalf of his city and region: “It is an honour that IDT has chosen Leuven for its primary European operation, and we are confident that IDT’s investment will benefit Belgium, IDT, and scientists throughout Europe.
Bird and Turtle Chromosomes Help Identify Dinosaur DNANews
Researchers have used bird and turtle DNA to extrapolate the chromosome structure of their common ancestor that lived around 260 million years ago – 20 million years before the dinosaurs first emerged. They were then able to trace the evolution of avian and non-avian dinosaur DNA through to the present day.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE